首页> 美国卫生研究院文献>Gastroenterology Hepatology >Evolving New Strategies for the Medical Management of Chronic Hepatitis B Virus Infection
【2h】

Evolving New Strategies for the Medical Management of Chronic Hepatitis B Virus Infection

机译:慢性乙型肝炎病毒感染医疗管理的不断发展新战略

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Is a cure for chronic hepatitis B virus (HBV) infection possible? Hepatitis C virus infection is now routinely cured medically. There is a growing expectation that new drugs for the management of chronic HBV infection should provide substantial benefit over and above that of current chronic HBV medications, if not be curative. Although the definition of medically induced cure for chronic HBV infection varies, most include sustained off-drug absence of viremia and negativity for other virologic markers. There are currently more than 29 drugs in the pipeline being tested for the management of chronic HBV infection. This article discusses the potential drugs with respect to their possible contributions to achieving medically induced cure.
机译:是否可以治愈慢性乙型肝炎病毒(HBV)?丙型肝炎病毒感染现已在医学上常规治愈。人们越来越期望,用于治疗慢性HBV感染的新药物,如果不能治愈,其疗效应超过目前的慢性HBV药物。尽管医学上诱导治疗慢性HBV感染的定义各不相同,但大多数都包括持续的非药物性病毒血症和其他病毒学标志物的阴性。目前,有29种以上的药物正在测试中,以管理慢性HBV感染。本文讨论了潜在药物对实现医学诱导治愈的可能贡献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号